us Good strong $XX.X on million. afternoon, increase Kendall. joining another flows call. positive you $X million investor $XXX,XXX, for year-over-year a positive with of today's Thanks, in cash revenue, of operating XX% We everyone, delivered and EBITDA adjusted and thank quarter
year, generated half million the of up XX% We and with the in operations. For revenues cash the flow and from first debt. were second of $X no $XX.X we cash ended million quarter
This consistent on deliver third to the even over million quarter break cash demonstrates marks consecutive basis. revenues our a of $XX flow and ability
revenue. net Our X% our profitable E-commerce e-commerce business remains most up quarter we as revenue year-over-year in was largest the growth. source of second on consistent and focused
on takeover while searched spend top pages. Specifically, on that and we reduced Amazon quarter, year, brand of during we channel. homepage campaigns last website revamping reducing have the re-targeted consumers significantly the who creative our funnel last nitrogen to true spend our Compared social and while search landing
company was from total and the revenues, XX.X% in and expense marketing XX.X% was net the quarter. sales significant reduction down For prior-year sequentially, a of which
overall our to pleased optimize made date, investments progress marketing ways to with adjustments While we a for are efficiency. we the continue look on with focus and to
through partner marketing Niagen Niagen Tru defenses a with Tru of Immune COVID-XX with the and bolstering a sell in They Kong second the remains positive. the and/or the strategic revenues increased prior immune is Niagen recently with of concept in year Watson's million valued robust with combining Immune Niagen which light Loyal of Niagen period. Tru consumers Tru launched $X Early online. awareness store importance beauty, during of especially in Tru Hong stacking, double pandemic. surrounding involves quarter are resonating campaign
Tru Watson's Hong Niagen hair, nails supplement their for a a new Niagen the by award-winning of influencer awarded campaign actress beauty skin, sell-through reported our in portfolio, was also best beauty core and well-known best beauty on anti-aging and at featuring supplement Rounding back award strong product for XXXX Tru Watson's the the out Kong. ceremony.
expand the that in a market sell in XX,XXX campaigns. recognize cross-border to Watson's for approval stores efforts retail through Hat remains we fully and Blue and Outside China, of China with region this China longer country, a Kong, market Tru of been Sinopharm the Hong taking Watson's of which is strategically partnering existing are capturing our anticipated. important cross-promotions Sinopharm ChromaDex sales has we in redoubling nearly to beyond combined business, have and and opportunity. Niagen tremendous than importance footprint on
iHerb, sales one our are strategic and of off Niagen, Tru solid Additionally, new to a who I'd highlight of to partners, like start.
for one best XXX presence and worldwide. the offers sales international States. countries. of Of iHerb established platform note, with million XX% than more nearly a in As the industry strong XX active outside iHerb has brands the number subscribers generated supplements the across United
By marketing budget, leading extensive and e-commerce expand our to own business reach. our the partnering with network including distribution and e-commerce aim we the global in wellness its retailer complement health and space,
nitrogen Our year-over-year by the quarter. grew in business ingredient XX% second
multi-ingredient longtime while work later contributor was extension, Nestle and by year. a on launch strategy retail its and we the current has to has quarter future with not supplement this expansion strong trends whose for large continue recently specialty Niagen their life This expansion Niagen portfolio, partner driven for results, first our plans to H&H gained momentum,
a by over Importantly, in development in There's growing the Niagen. business external we reputation studies preclinical NAD which over supported Niagen clinical of celebrated we through scientific uncovering age. of of decade importance as continues This nicotinamide part NAD award-winning or ChromaDex's the reputation global awareness by and studies health a to research evidenced with NAD published as excellence of pipeline grow the trusted potential full human as published programs, ChromaDex's on of as riboside our began as brand. in Niagen the community in authority our XX XXX through the
completed help trials make with on listed value happen. this has program. registered XX% using trials.gov to is institutions clinical and scientific testament a produced and academic Niagen, ongoing We encourage our strong value the tremendous behind over products of our rigor ERP which NR or this relationships of
advances peer-reviewed in in over reviewed in states body concluding the the on clinical of science article month, Last the humans. XX nicotinamide the and last role has shown years, a of treatment published potential reduction of play that studies diseases inflammatory NR may riboside an severe in
cells. in found consistently Specifically, and to metabolites shown NR the authors that occasionally related in blood was white increase and NAD whole blood
a consistency collection We for risk NAD with the typically follows many extensive proven series date other published NR blockbuster of path studies levels factor research demonstrates supplementation studies. research by to and and followed A to agree the which diseases. novel The date ingredients, is boost exciting of respect old safety known great to with for a studies age-related NR oral reduce inflammation. clinical to begin ingredient preclinical blood clinical progress of
the hope are call We further research over upholding a to integrity researchers this advance serves At underway. on as scientific for clinical paramount standards article the of of studies and highest continue to NR action and NR to importance. to state XX support we additional ChromaDex science, research there is CERP through the
this independent research contrast in the in funded of over by to CERP third By approach, a the As industry. In trust adopting dietary studies skepticism we entirely the supplement of are commitment via this level and and foster significant investigator industry research. conducted funded to XX% initiated a parties. testament around
year. the industry on those Tech, the Europe, Research Clinical CERP in Labio by leading NR biotech online among article past outlet Alzheimer's independent media an in note, scientific over Parkinson's disease the named the diseases top in Of and recent for through Published advances
It's Alzheimer's Dementia in from has full potential article featured mentioned the alongside NR. Blocks therapeutics an Additionally, consumers work and and diseases. Memory titled to our weekly been promising Alzheimer's true of for that doing CERP uncover is a Boosts testament Mood, Niagen to suffering these also BX ingredient the
precursor Niagen, At ChromaDex, portfolio support markets portfolio efficient We rolling in many competitive a is and on to products position. possible the protect knew most IP global developed property behind to have as research our a CERP, deep Tru wanted the intellectual our the market, we an to that. our improve the NAD match NAD us that priority mission as for lives on was with and early to DNA. out
or recently Delivers discussed Strong impressive the were A article scientists ChromaDex's featured key Longevity patents, in titled in licensed the Niagen Portfolio range The and article our methods patents. manufacturing, Competitive Space. over including patents, Longevity of in an XX protecting related owned of other array Edge of of Patent a include a use, NAD methods These of of Two matter precursors. composition Technology and
around launch and our enforceable and NR protection the strongest allowing patents ChromaDex in internationally both through in confidence most patents, future Collectively, The Europe, among with Australia, the as such for domestically decade, in moat strong to provide China, these the markets innovations U.S. business. next Canada. the latter and
important And inventions to to so in to seen other Recently the therapy extended feel aging the we've benefits consumers. that prevent remain awareness action mechanisms overall for and to we've as space, the delivery take healthy trusted supplementation a we to like of defend diligently NAD worked NAD infringement. leader of protect IV and it's more
with articles Tru and Time XXXX Bazaar in media date. Aging Business almost as outlets Niagen of mentions Just last News, such mentioning UK month, there in such to were context Healthy Harper's supplements, four popular the XX editorial including
The NAD be to Kendall U.S. five Jenner NAD piece preferred One NAD therapies Tru aging. in one That, food take And discussing can one of prevent number accessible to This, those in and a nutrition website. article was supplement. Niagen to celebrities Hailey showcased focused and highlighted the outlets top for uncomfortable boosting NAD alternative Bieber such world's and the how who and IV that an Eat inject IV the as Not on these of look media hours
featured article benefits believer, live The true age. our Niagen elevating discussing same the later NAD of with ran longer, which publication are biohacking who Tru celebrities to longtime about as Brooke Burke, we an
selling retailers, overall Amazon was are While one the are Walmart, longer and FDA growing, and supplement, NAD and by U.S. products reputable banned NAD NMN. sales no including awareness NMN
cannot safety compared we've want Certain from it NMN a and continue company a to cell directly that extensive proper accumulate, apart data is notifications, to States. if own testing, precursor ingredient Consumers to websites. as must supplemented, Tru knowingly data when with the superior buy in an cross that the product membrane companies regulatory reinforce NR. United converted contrast in and Niagen Niagen consider NMN third-party be continue carefully they to compliance NMN the years, illegal on their should into a efficiency its stands known And for selling which is supplement sell with first what
superior. to This was labeled mice once Anthony is NMN thus to before publication that the be which demonstrated again list is administered expanding NMN riboside demonstrated converted being in an late for converted latest group in NR studies the nicotinamide the This must of Sauve, from led is by a definitively. utilized and and nicotinamide to MAD that recent synthesis. Isotopically show NR
Importantly, to is NR today or available want Niagen elevate NAD readily who for consumers legally levels.
Amazon, our is some of sales removal by We a are like NMN seeing limiting still on the potential. NMN platform the shift on but upside to the companies direct benefit sales from currently
we opportunities near-term our to future, to several look see we extend As the market.
initiatives of effort. later We worked diligently to they have year, next year culmination early and several that this materialize are years represent or the expected on of
as precursors. NAD is and as new improve This nutrition through new mission overarching health lives to possible. Our human the beyond supplementation mission as company into and extends many categories
regulatory to these we market global partner more the over Science NAD XX leading authority future We foundation in researchers the supported built by updates. to last a the years of and as on and opportunities look trusted forward sharing All are authorities. expansion have
now Q&A would onto to in the I discuss to in closing results over call Brianna then like quarter's turn remarks. detail more And Brianna? to and the
